Two Sigma Investments’s LianBio American Depositary Shares LIAN Stock Holding History

Two Sigma Investments’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,291	Closed	-$59.4K	–	3485
2023 Q4	$59.4K	Buy	+13,291	New	+$45.7K	﹤0.01%	2981
2022 Q1	–	Sell	-37,365	Closed	-$230K	–	4648
2021 Q4	$230K	Buy	+37,365	New	+$427K	﹤0.01%	3827

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Two Sigma Investments's LIAN Position: Q1 2024 in Review

Two Sigma Investments sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 13,291 shares — an estimated $59.4K sold.

Two Sigma Investments first reported a position in LIAN in Q4 2021 and held it in 2 quarters. The position peaked at $230K in Q4 2021. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Two Sigma Investments reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Two Sigma Investments sold 13,291 LianBio American Depositary Shares shares in Q1 2024, an estimated $59.4K.
Two Sigma Investments first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 2 quarters.
Two Sigma Investments's LianBio American Depositary Shares position peaked at $230K in Q4 2021.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.